Brain Prediction Failure Explains Voice Hearing in Schizophrenia

Psychologists from UNSW Sydney have conducted a groundbreaking study that provides the most compelling evidence to date, indicating that auditory hallucinations in schizophrenia stem from a disruption in the brain's ability to distinguish its own internal monologue from external noises. This investi

Psychologists from UNSW Sydney have conducted a groundbreaking study that provides the most compelling evidence to date, indicating that auditory hallucinations in schizophrenia stem from a disruption in the brain's ability to distinguish its own internal monologue from external noises. This investigation reveals how the brain might erroneously classify self-generated mental chatter as auditory input originating from the external environment.

The findings, detailed in the prestigious Schizophrenia Bulletin journal, also illuminate a promising avenue for discovering biological indicators specific to schizophrenia. Such markers are crucial, given the absence of reliable diagnostic tools like blood analyses, neuroimaging scans, or laboratory assays that can definitively pinpoint this psychiatric disorder.

For years, Professor Thomas Whitford from the UNSW School of Psychology has delved deeply into the mechanisms of inner speech, comparing its functioning in healthy subjects and those diagnosed with schizophrenia spectrum conditions.

He describes inner speech as the internal dialogue that quietly articulates one's thoughts—covering activities, future plans, or observations in the moment.

A significant portion of individuals encounter this inner voice frequently, sometimes subconsciously, although a minority report never experiencing it.

The study demonstrates that during vocalization—whether articulated aloud or merely conceptualized mentally—the brain region dedicated to interpreting external auditory stimuli exhibits diminished activity. This occurs because the brain anticipates the auditory profile of one's own voice. However, in individuals prone to hearing voices, this anticipatory process falters, prompting the brain to perceive the voice as originating from an external source.

Brainwave Patterns Validate a Persistent Hypothesis

Professor Whitford emphasizes that these discoveries robustly endorse a longstanding hypothesis in psychiatric research, which posits that the auditory hallucinations characteristic of schizophrenia arise when a person's internal speech is misconstrued as originating externally.

This concept has circulated in scientific circles for approximately half a century, yet empirical validation has proven challenging due to the subjective and inaccessible nature of inner speech.

Measuring it poses unique difficulties, but one effective method involves electroencephalography (EEG), which captures the brain's electrical signals. Although inner speech remains inaudible, it elicits neural responses; in neurotypical individuals, engaging in silent articulation mirrors the neural suppression observed during overt speech.

Conversely, those who experience auditory hallucinations fail to exhibit this suppression. Remarkably, their neural response intensifies during inner speech, mimicking the reaction to an unfamiliar external voice, which could account for the vivid realism of these perceptions.

Experimental Examination of Auditory Prediction Mechanisms

To rigorously investigate this phenomenon, the research team categorized participants into three distinct cohorts. The initial group comprised 55 individuals with schizophrenia spectrum disorders who had reported auditory verbal hallucinations (AVH) in the preceding week. The second cohort included 44 schizophrenia patients without a history of AVH or those whose episodes were not recent. The control group consisted of 43 psychiatrically healthy volunteers devoid of schizophrenia history.

All participants donned EEG headsets and received audio stimuli via headphones. Periodically, they were instructed to mentally rehearse pronouncing either 'bah' or 'bih' while simultaneously hearing one of these syllables broadcast externally. Crucially, the alignment between the imagined syllable and the played sound was unpredictable.

In the healthy cohort, neural activity in the auditory cortex—a key area for sound and language processing—diminished precisely when the mentally rehearsed syllable corresponded to the external audio. This suppression reflects the brain's accurate forecasting of the sensory input, akin to self-speech dynamics.

Participants with recent AVH displayed the inverse response: heightened neural activation occurred specifically when their inner speech aligned with the external stimulus.

As Professor Whitford notes, "Their neural systems amplified responses to matching inner and outer sounds, directly contrasting the pattern in healthy controls."

This inversion of the typical suppression mechanism implies a fundamental impairment in predictive processing among those actively hallucinating, potentially leading to the externalization of their internal voice.

The non-hallucinating schizophrenia group exhibited intermediate neural patterns, bridging the responses of the healthy and AVH groups.

Implications for Advancing Schizophrenia Investigations

The scientists assert that these outcomes furnish the most robust validation to date for the notion that schizophrenia patients perceive their own imagined utterances as extraneous voices.

Professor Whitford reflects, "While this hypothesis was intuitively sound—suggesting individuals hear their thoughts vocalized externally—our innovative methodology delivers the most precise and compelling evidence yet."

Moving forward, the team intends to determine if this distinctive neural signature can forecast the onset of psychosis in at-risk populations. Positive results could enable earlier detection and intervention, markedly improving prognosis.

He adds, "This neural metric holds substantial promise as a biomarker for emerging psychosis."

In the broader context, unraveling the neurobiological underpinnings of schizophrenia symptoms represents an essential prerequisite for innovating targeted, efficacious therapies that address the disorder at its core.